| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |